4//SEC Filing
Poirier Michael S. 4
Accession 0001493152-22-021321
CIK 0001460702other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:16 PM ET
Size
5.4 KB
Accession
0001493152-22-021321
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Award
Stock Option (Right to Buy)
2022-07-11+375,000→ 375,000 totalExercise: $0.51Exp: 2032-07-11→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
Documents
Issuer
Qualigen Therapeutics, Inc.
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001812504
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:16 PM ET
- Size
- 5.4 KB